Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenue will be 30,63 billion USD (consensus estimates). This is slightly lower than 2018's revenue of 31,9 billion USD.
The analysts expect for 2020 a net profit of 4,86 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 2,81 USD. Based on this the price/earnings-ratio is 31,72.
Analysts expect a dividend of 1,44 USD per share. Thus the dividend yield equals 1,62 percent. The average dividend yield of the pharmaceutical companies is a relatively high 6,35 percent.
Abbott's market capitalization is based on the number of outstanding shares around 156,5 billion USD. The Abbott stock was the past 12 months quite volatile. Since last April the stock is 19 percent higher. This year the stock price moved between 62 and 92 dollar. Since 2008 the stock price is almost 256 percent higher.
Click here for dividend . On Friday the stock closed at 89,14 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.